Laysan Bio, Inc., a subsidiary of Gannet BioChem

Poly(ethylene glycol) and PEGylation technology have changed dramatically in the past decade. PEG technology has moved from an interest of study in the academic world to a proven technology that enhances or enables ten products with over seven billion dollars a year in sales. These products are changing the lives of thousands with SCIDS, macular degeneration, acromegaly and chronic hepatitis C.

We, the founders of Laysan Bio, have had extensive experience with PEG and PEGylation and have been fortunate enough to work on supporting the drugs mentioned above. We have enjoyed the work we have done in this area, and very much want to continue to offer such a service to you. In starting Laysan Bio, our intention is to offer the highest quality PEG technology, best service and a collaborative environment to help you realize your current research goals. We understand that the work you are doing is original and therefore might require an original solution.